152 related articles for article (PubMed ID: 8003039)
21. Metabolism of n-hexane by rat liver and extrahepatic tissues and the effect of cytochrome P-450 inducers.
Crosbie SJ; Blain PG; Williams FM
Hum Exp Toxicol; 1997 Mar; 16(3):131-7. PubMed ID: 9088965
[TBL] [Abstract][Full Text] [Related]
22. Roles of cytochrome P450 3A enzymes in the 2-hydroxylation of 1,4-cineole, a monoterpene cyclic ether, by rat and human liver microsomes.
Miyazawa M; Shindo M; Shimada T
Xenobiotica; 2001 Oct; 31(10):713-23. PubMed ID: 11695850
[TBL] [Abstract][Full Text] [Related]
23. Unchanged cytochrome P450 3A (CYP3A) expression and metabolism of midazolam, triazolam, and dexamethasone in mdr(-/-) mouse liver microsomes.
Perloff MD; von Moltke LL; Cotreau MM; Greenblatt DJ
Biochem Pharmacol; 1999 Jun; 57(11):1227-32. PubMed ID: 10230766
[TBL] [Abstract][Full Text] [Related]
24. Oxidative metabolism of monensin in rat liver microsomes and interactions with tiamulin and other chemotherapeutic agents: evidence for the involvement of cytochrome P-450 3A subfamily.
Nebbia C; Ceppa L; Dacasto M; Carletti M; Nachtmann C
Drug Metab Dispos; 1999 Sep; 27(9):1039-44. PubMed ID: 10460804
[TBL] [Abstract][Full Text] [Related]
25. Metabolism of tacrolimus (FK 506) in rat liver microsomes. Effect of rifampin and dexamethasone.
Prasad ; Tata NV; Subbotina N; Burckart G; Swaminathan A; Gusev AI; Hercules DM; Venkataramanan R
Res Commun Mol Pathol Pharmacol; 1997 Apr; 96(1):107-10. PubMed ID: 9178371
[TBL] [Abstract][Full Text] [Related]
26. Negative regulation by dexamethasone of fluvastatin-inducible CYP2B expression in primary cultures of rat hepatocytes: role of CYP3A.
Kocarek TA; Reddy AB
Biochem Pharmacol; 1998 May; 55(9):1435-43. PubMed ID: 10076536
[TBL] [Abstract][Full Text] [Related]
27. CYP3A-inducing agents and the attenuation of uroporphyrin accumulation and excretion in a rat model of porphyria cutanea tarda.
Franklin MR; Phillips JD; Kushner JP
Biochem Pharmacol; 2000 Nov; 60(9):1325-31. PubMed ID: 11008126
[TBL] [Abstract][Full Text] [Related]
28. Involvement of CYP3A1, 2B1, and 2E1 in C-8 hydroxylation and CYP 1A2 and flavin-containing monooxygenase in N-demethylation of caffeine; identified by using inducer treated rat liver microsomes that are characterized with testosterone metabolic patterns.
Chung WG; Roh HK; Kim HM; Cha YN
Chem Biol Interact; 1998 May; 113(1):1-14. PubMed ID: 9630843
[TBL] [Abstract][Full Text] [Related]
29. In vivo induction of cytochrome P450 CYP3A expression in rat leukocytes using various inducers.
Mahnke A; Roos PH; Hanstein WG; Chabot GG
Biochem Pharmacol; 1996 Jun; 51(11):1579-82. PubMed ID: 8630100
[TBL] [Abstract][Full Text] [Related]
30. Induction of cytochrome P450 3A by metyrapone in human hepatocyte culture.
Wright MC; Maurel P; Paine AJ
Hum Exp Toxicol; 1996 Mar; 15(3):203-4. PubMed ID: 8839205
[No Abstract] [Full Text] [Related]
31. Combined action of phenobarbital and dexamethasone on the activity of rat liver P450 system.
Monostory K; Vereczkey L
Acta Pharm Hung; 1993 Sep; 63(5):296-300. PubMed ID: 8249615
[TBL] [Abstract][Full Text] [Related]
32. Substrate-regulated, cAMP-dependent phosphorylation, denaturation, and degradation of glucocorticoid-inducible rat liver cytochrome P450 3A1.
Eliasson E; Mkrtchian S; Halpert JR; Ingelman-Sundberg M
J Biol Chem; 1994 Jul; 269(28):18378-83. PubMed ID: 8034584
[TBL] [Abstract][Full Text] [Related]
33. Effect of Taxol on cytochrome P450 3A and acetaminophen toxicity in cultured rat hepatocytes: comparison to dexamethasone.
Kostrubsky VE; Lewis LD; Wood SG; Sinclair PR; Wrighton SA; Sinclair JF
Toxicol Appl Pharmacol; 1997 Jan; 142(1):79-86. PubMed ID: 9007036
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo effects of the arylamine human immunodeficiency virus protease inhibitor 4R-(4alpha,5alpha,6beta, 7beta)-1-[(3-(1-imidazoylcarbamoyl)phenyl)methyl]-3-[(3-aminophenyl)m ethyl]hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-2H-1, 3-diazepin-2-one (SD894) on rat hepatic cytochrome P450 2B and 3A.
Grubb MF; Diamond S; Christ DD
Drug Metab Dispos; 1997 Dec; 25(12):1424-8. PubMed ID: 9394033
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of 7-benzyloxy-4-trifluoromethylcoumarin, some other 7-hydroxy-4-trifluoromethylcoumarin derivatives and 7-benzyloxyquinoline as fluorescent substrates for rat hepatic cytochrome P450 enzymes.
Renwick AB; Lavignette G; Worboy PD; Williams B; Surry D; Lewis DF; Price RJ; Lake BG; Evans DC
Xenobiotica; 2001 Dec; 31(12):861-78. PubMed ID: 11780761
[TBL] [Abstract][Full Text] [Related]
36. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
[TBL] [Abstract][Full Text] [Related]
37. Differential induction of rat hepatic cytochromes P450 3A1, 3A2, 2B1, 2B2, and 2E1 in response to pyridine treatment.
Kim H; Putt DA; Zangar RC; Wolf CR; Guengerich FP; Edwards RJ; Hollenberg PF; Novak RF
Drug Metab Dispos; 2001 Mar; 29(3):353-60. PubMed ID: 11181506
[TBL] [Abstract][Full Text] [Related]
38. Induction of liver microsomal cytochrome P450 in cynomolgus monkeys.
Bullock P; Pearce R; Draper A; Podval J; Bracken W; Veltman J; Thomas P; Parkinson A
Drug Metab Dispos; 1995 Jul; 23(7):736-48. PubMed ID: 7587963
[TBL] [Abstract][Full Text] [Related]
39. Midazolam is a phenobarbital-like cytochrome p450 inducer in rats.
Hoen PA; Bijsterbosch MK; van Berkel TJ; Vermeulen NP; Commandeur JN
J Pharmacol Exp Ther; 2001 Dec; 299(3):921-7. PubMed ID: 11714877
[TBL] [Abstract][Full Text] [Related]
40. Association of cytochrome P450 induction with oxidative stress in vivo as evidenced by 3-hydroxylation of salicylate.
Strolin-Benedetti M; Brogin G; Bani M; Oesch F; Hengstler JG
Xenobiotica; 1999 Nov; 29(11):1171-80. PubMed ID: 10598750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
